Add BrightSurf on Google Email

Real-world studies confirm effectiveness of bulevirtide to treat chronic hepatitis D

Three real-world studies published in the Journal of Hepatology and JHEP Reports demonstrate that bulevirtide is well-tolerated and safe for treating chronic hepatitis delta. Long-term suppressive therapy with BLV monotherapy has the potential to reduce viral replication and improve liver function in difficult-to-treat patients.

SourceElsevier·JournalJournal of Hepatology·TypeExperimental study·DateMar 20, 2023

Wheat’s ancient roots of viral resistance uncovered

Researchers have uncovered the ancient roots of a gene in wheat that provides resistance to the devastating Wheat Yellow Mosaic Virus, which causes significant economic losses. The discovery could lead to more resistant wheat cultivars, increased crop yields, and reduced use of harmful fungicides.

SourceUniversity of Melbourne·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateMar 6, 2023

Study reinforces potential use of zika virus to combat prostate cancer but points to possible side-effect

Researchers analyzed zika virus effects on tumor cells and healthy cells, discovering its potential to treat prostate cancer but also triggering a persistent inflammatory process that damages the male reproductive system. The study's findings suggest long-term treatment could lead to recurrence of prostate cancer.

SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournalJournal of Proteome Research·DateMar 1, 2023

The Access to Advanced Health Institute announces $3M award to develop an intranasal pan-viral countermeasure against respiratory viruses

AAHI will develop a prototype nasal spray using its novel adjuvant formulation platform, promising to shorten timelines for emergency response to and mitigate impacts from biological threats. The project aims to create a temperature-stable and broadly protective nasal spray against multiple respiratory viruses.

Oncolytic virus treatment produces promising results in patients with triple-negative breast cancer

A phase 2 trial found that talimogene laherparepvec combined with chemotherapy provided strong responses and immune cell activation in 45.9% of patients with early stage triple-negative breast cancer. Tumor samples showed high levels of tumor-fighting T cells, indicating a potential for improved outcomes.

SourceH. Lee Moffitt Cancer Center & Research Institute·JournalNature Medicine·TypeRandomized controlled/clinical trial·DateFeb 9, 2023

How does COVID-19 compare with bacterial and viral pneumonia for older patients in intensive care?

A recent study published in the Journal of the American Geriatrics Society found that COVID-19 is associated with higher mortality rates compared to bacterial and viral pneumonia among older patients in intensive care units. The study analyzed data from over 11,500 patients aged 70 years and older who were admitted to Dutch ICUs, revea...

SourceWiley·JournalJournal of the American Geriatrics Society·DateFeb 8, 2023

A severe begomovirus-satellite DNA disease complex in Texas lower Rio Grande valley okra fields and its potential threat to cotton production: New “focus on cotton” webcast

A severe begomovirus-satellite DNA disease complex has been detected in okra fields in the lower Rio Grande Valley area of Texas, posing a significant threat to cotton production. The complex involves the exotic cotton leaf curl Gezira virus and its associated satellite DNA molecules.

Scientists pinpoint protein that helps cancer-causing viruses evade immune response

Researchers have discovered that KSHV and EBV use the human protein barrier-to-autointegration factor 1 (BAF) to evade the innate immune response. This allows the viruses to spread and cause disease. Disrupting BAF activity with targeted therapies could prevent virus replication and transmission.

SourceUniversity of North Carolina Health Care·JournalNature Communications·TypeExperimental study·DateFeb 6, 2023

Coffee with milk may have an anti-inflammatory effect

A new study from the University of Copenhagen suggests that combining proteins and antioxidants in foods like coffee with milk may have an anti-inflammatory effect in humans. The researchers found that immune cells treated with this combination were twice as effective at fighting inflammation as those with only polyphenols.

SourceUniversity of Copenhagen - Faculty of Science·JournalJournal of Agricultural and Food Chemistry·DateJan 30, 2023

Eating viruses can power growth, reproduction of microorganism

A team of researchers at the University of Nebraska-Lincoln has discovered that certain microorganisms, such as Halteria, can eat high numbers of chloroviruses, which are known to infect green algae. This finding suggests that virovory, a virus-only diet, can support physiological growth and even population growth in an organism.

SourceUniversity of Nebraska-Lincoln·JournalProceedings of the National Academy of Sciences·DateDec 26, 2022

Scientists uncover biological explanation behind why upper respiratory infections are more common in colder temperatures

A newly discovered immune response inside the nose fights off viruses, but is suppressed by colder temperatures, making an infection more likely to occur. The study offers the first biological mechanism to explain why viruses like COVID-19 spike in colder seasons.

SourceMass Eye and Ear·JournalJournal of Allergy and Clinical Immunology·TypeExperimental study·DateDec 6, 2022

Discovery of antibody structure could lead to treatment for Crimean Congo Hemorrhagic Fever virus

A research team at the University of California, Riverside has discovered the structure of a human monoclonal antibody that protects against Crimean Congo Hemorrhagic Fever virus. The study provides insights into fighting a broad range of viral strains and could lead to targeted therapeutics for infected patients.

SourceUniversity of California - Riverside·JournalNature Communications·TypeExperimental study·DateNov 28, 2022

Gene-delivering viruses reach the brain in step toward gene therapy for neurological diseases

Researchers have engineered a family of adeno-associated viral vectors that can deliver cargo to the primate brain, offering a safer and more efficient way to treat genetic diseases. The PAL family of AAVs has been shown to be three times better at delivering their cargo into the brain than current leading AAV delivery vehicle AAV9.

SourceBroad Institute of MIT and Harvard·JournalMed·TypeExperimental study·DateNov 22, 2022

D-Amino acids: Signaling severity in viral infection

Researchers found reduced levels of D-amino acids in patients with severe COVID-19 and IAV infection, suggesting they could be used as biomarkers. Supplementation with D-alanine improved survival rates and clinical outcomes in mouse models of both infections.

SourceOsaka University·JournalBiochimica et Biophysica Acta·TypeObservational study·DateNov 21, 2022

Video surveillance, now for viruses

Researchers at Duke University have developed a new method called 3D Tracking and Imaging Microscopy (3D-TrIm) to capture real-time 3D footage of viruses approaching cells. This technique combines two microscopes in one, allowing scientists to study the early moments before infection begins and how viruses navigate complex barriers.

SourceDuke University·JournalNature Methods·TypeImaging analysis·DateNov 10, 2022

Control hub for skin inflammation discovered

Researchers at the University of Bonn have identified a new signaling pathway that triggers inflammatory responses in the skin after UV damage. This pathway involves the activation of p38 molecularly modifying NLRP1, a critical switch for inflammation, and initiates the assembly of inflammasomes.

SourceUniversity of Bonn·JournalJournal of Experimental Medicine·DateNov 2, 2022

Climate change could make High Arctic fertile ground for emerging pandemics: uOttawa study

A novel genetic analysis by University of Ottawa researchers reveals that climate change could lead to an increased risk of viral spillover in the High Arctic. This increased risk may result in new viruses infecting previously uninfected hosts, potentially leading to emerging pandemics.

SourceUniversity of Ottawa·JournalProceedings of the Royal Society B Biological Sciences·TypeComputational simulation/modeling·DateOct 19, 2022

Coronavirus formation is successfully modeled

Researchers at the University of California, Riverside successfully modeled the formation of SARS-CoV-2 using coarse-grained models, revealing key ingredients and components contributing to its packaging. The study could inform the design of effective antiviral drugs to arrest coronaviruses in their assembly stage.

SourceUniversity of California - Riverside·JournalViruses·TypeComputational simulation/modeling·DateOct 3, 2022